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An impressively large meta-analysis in
this issue of PLoS Medicine shows that
physical activity modifies the effect of a
common genetic trait on body mass. It was
already known that certain variants of the
‘‘fat mass and obesity associated’’ (FTO)
gene predispose to weight gain, but this
article shows that this effect is weaker
among physically active persons [1].
The authors argue that this is important
because many people have a determinist
view of genes and may think that when
something is written in your genetic code,
nothing can be done to alter the course of
fate. The study shows that view to be overly
simplistic: genes may predispose to weight
gain, but this weight can be lost by extra
physical activity. And in time, studies into
the causes of this gene–behaviour interac-
tionmaylead to newtreatments forobesity.
Limited Public Health Relevance
Encouraging as that news is, the imme-
diate relevance of this study for public
health is limited. The logical consequence
of genomic research is screening. Genetic
screening for obesity is already commer-
cially available. The results tell the custom-
er their lifetime risk of obesity and how
much that differs from the population
average. The validity of such direct-to-
consumer genomic tests is largely unknown
[2], and before rushing to screening pro-
grammes, some critical reflection on the
role and risks of genetic screening for
susceptibility to behavioural risk factors is
warranted. There are at least four reasons
why screening individuals for genes that
predispose to obesity makes little clinical
sense and may even do harm. Genetic
screening for obesity has limited predictive
power, is unlikely to inform therapeutic
decisions, does not add to body mass index
(BMI) as predictor of disease, and may
distract from the societal changes that most
experts think are needed to reduce the
prevalence of obesity.
Weak Predictive Power
First, individual genetic traits do not
seem to have all that much influence on
body mass. The impact of genetic traits on
population health is a product of the size
of the health effect for the affected
individual (penetrance) and the frequency
of the trait in a population. The rs9939609-
variant of the FTO gene studied by
Kilpela ¨inen et al. is common, but although
it is the strongest known susceptibility locus
for common obesity, its penetrance is low.
A single copy is associated with a 23%
increased risk of obesity and a correspond-
ingly modest effect on body mass of
0.36 kg/m
2 (about 1 kg) on average. Mod-
elling studies have shown that even when
testing for multiple genetic traits with such
low predictive power, screening is unlikely
to be worthwhile [3,4]. And since genetic
traits with the highest predictive power are
most likely to be the first ones found, it is
unlikely that genetic traits with larger
impact on body mass will ever be found.
No Change in Therapeutic
Options
Second, testing for genetic traits that are
associated with obesity makes no differ-
ence in the advice to overweight persons:
increased physical activity and a healthy
diet are indicated regardless of the genes.
If the results of genetic testing would
motivate and empower persons to do
better than average [5], such testing might
add value, but with equal right one may
speculate that others could feel discour-
aged to improve health behaviours. Either
way, beyond the suggestion that genomic
screening may spur further screening for
early stages of disease, the evidence on
how genetic testing influences health
behaviours remains largely anecdotal and
speculative [2,6]. Theoretically, genomic
profiling might indicate the most efficient
way to lose weight and reduce the risk of
disease, but given the limited accuracy
with which we can measure diet and (until
recently) physical activity levels, it may
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Linked Research Article
This Perspective discusses the fol-
lowing new study published in PLoS
Medicine:
Kilpela ¨inen TO, Qi L, Brage S, Sharp
SJ, Sonestedt E, et al. (2011) Physical
Activity Attenuates the Influence of
FTO Variants on Obesity Risk: A
Meta-Analysis of 218,166 Adults
and 19,268 Children. PLoS Med
8(11): e1001116. doi:10.1371/journal.
pmed.1001116
Ruth Loos and colleagues report
findings from a meta-analysis of mul-
tiple studies examining the extent to
which physical activity attenuates
effects of a specific gene variant,
FTO, on obesity in adults and chil-
dren. They report a fairly substantial
attenuation by physical activity on
the effects of this genetic variant on
the risk of obesity in adults.
The Perspective section is for experts to discuss the
clinical practice or public health implications of a
published study that is freely available online.
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prediction models.
No Better Prediction of Disease
The third and most fundamental reason
for the futility of screening for obesity-
enhancing genetic traits is that it adds no
predictive value to existing disease predic-
tion tools. This is perhaps best illustrated
in the original study that reported on the
significance of FTO for obesity. Frayling
et al. wrote that ‘‘the association between
FTO SNPs and type 2 diabetes was
abolished by adjustment for BMI, which
suggests that the association of these SNPs
with T2D risk is mediated through BMI’’
[7]. Of course, a test that adds no
predictive power to a simple measurement
of BMI is not worth doing.
Wrong Focus
Fourth, screening raises some further
critical issues at the societal level, notably
that ‘‘a focus on genetic susceptibilities
may be used to shift the focus of public
health intervention and policy to the
individual level and away from larger
social, economic, and political factors that
are fundamental to the production of
human health and illness’’ [8]. This
criticism is very relevant in the case of
obesity, as many obesity experts argue that
the obesity epidemic is related exactly to
those larger social, economic, and political
factors (the ‘‘obesogenic’’ environment)
[9,10]. Genes may co-determine who
becomes obese, but our environment
determines how many become obese.
With the current state of technology, apart
from bariatric surgery the only solution for
the obesity epidemic lies in changes to the
environment so that it promotes physical
activity and a healthy diet. A focus on
individual genetic traits is a mere distrac-
tion and reinforces the popular view of
obesity as a problem that individuals have
to deal with, rather than one that requires
societal action.
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